Ann: Imugene completes $90 M placement and launches $5 M SPP, page-261

No chance at all of a dividend this FY
It would be a mistake even if there was a profit as IMU needs to re-invest into ongoing research as the highest priority!

If anything a further capital raise is more likely if they were to see a m&a opportunuty.

Future profits will be massive if they deliver on the research and postive trials which I think is very likely given the quality of their team.

Watching with interest and congrats to all those taking up their allocations with the bonus options (there is your future dividend right there)